This rare antimalarial is at the center of a war between scientists against the coronavirus.
In recent weeks, part of the war against the coronavirus pandemic has spread to the pharmaceutical field. With a controversy over the use of chloroquine to fight the virus that is decimating the planet. Donald Trump, the President of the United States of America, is a cantor of this antimalarial he praises as the panacea that has so far been able to save American lives threatened by the killer of the hour.
In a country that is among the ten most affected by the pandemic. After several weeks of hesitation, France ended up adopting chloroquine therapy. Emmanuel Macron states that this medication is administered to older patients. Senegal got involved with four new cases yesterday. Adding that this is an experiment, in combination with another molecule, which “gives satisfactory results”. Supporters of chloroquine can rely on Dr Didier Raoult.
The French infectious disease specialist and microbiology professor of emerging tropical infectious diseases and his research team prescribe the administration of hydroxychloroquine and azithromycin. The doctor conducted a clinical trial on 24 confirmed coronavirus patients.
And six days later, “only 25% of the cases were still carrying the virus”. While at the same time, “90% of patients treated without chloroquine in Nice and Avignon, would still be contagious at the end of this same period”. hydroxychloroquine being a molecule close to elsewhere, “several states have already included hydroxychloroquine or chloroquine in their therapeutic recommendations for the treatment of Covid-19 as soon as the symptoms of the virus are detected”.
The study, which was made public on March 22, immediately raised an outcry in the scientific and medical world. The team of Dr Didier Raoult is accused of methodological shortcomings. “On the basis of an essay which is absolutely questionable on a scientific level and which shows absolutely nothing when we look exactly at the figures and the way it was conducted, we expose people to a false hope of recovery”, denounces Karine Lacombe, head of the infectious diseases department at Saint Antoine hospital in Paris.
For the latter, “use a drug like that outside Marketing Authorization (Amm) by exposing people who take them to complications, without having checked the basic conditions of chloroquine, I think it is outside of any ethical approach. Even if this drug can potentially have activity, which has been demonstrated in vitro. ” Still, “it is extremely dangerous,” she knocked on the television news 13 on France 2 last Monday.
Lavoisier’s law on the molecular equation
In Cameroon, chloroquine, which had already almost disappeared from the pharmacy shelves, is also at the center of the debate. “No drug cures the coronavirus for the moment”, slices Manaouda Malachie, the Cameroonian Minister of Public Health.
“In fact, for the moment, we are treating the symptoms of the coronavirus,” says a doctor. Two patients who have already recovered their health in the country of Paul Biya. The country which, like many tropical countries, is content to align itself with the positions of developed countries, has so far engaged in the search for the causes of the virus and is on the trail of bats. And intends to locally manufacture brands at low prices for its populations plunged into psychosis, by seeing the spread of the virus at a speed that worries the authorities.
Behind this controversy, could be an economic war. The suspicion is maintained even in medical circles. French MP Joachim Son-Forget criticizes Karine Lacombe: “You must, when you intervene, declare your conflicts of interest since you have received money from Abbvie who produces kaletra and from Gilead who produces remdesevir (Sic) . The two alternatives to hydroxychloroquine, cheap and unprotected, “he wrote in a tweet.
Kaletra is an antiretroviral developed by the company Abbvie which I combine with other products, while remdesivir is an experimental antiviral developed by Gilead sciences against Ebola. These two protocols seem to have the backing of the European Union which gives them credit, in relation to hydroxychloroquine.
Marie Gisèle Kamanou is a mathematician and encouraged the use of chloroquine “Considering the law of the molecular equation, when the temperature rises, either one loving molecule the other, or it rejects it”. By applying it to the coronavirus, “when the virus arrives, if it finds the molecule of chloroquine which is already in the body and which is stronger, which rejects it”, explains the promoter of the theory of thermal shock .
Theory that promotes the transformation of everything organic into nutritious food necessary for the balance of the organism. To this end, the kinqueliba on the basis of which es; manufactured chloroquine, is according to the latter a convincing solution to overcome the coronavirus.
–
